🟢 WORK Medical Technology Group is trading 14.84% up in pre-market after H1 results and proposed financing

WORK Medical Technology Group is trading 14.84% up at $2.55 after investors reacted to August 14, 2026, half-year results and proposed financing.

• Sales increased to $5.41 million from $4.54 million; net loss was $3.41 million versus prior-year profit.
• Planned private-placement proceeds of approximately $2.125 million are for expansion and working capital.
• Active pre-market trading extends the August 14, 2026, close of $2.22. Financing remained subject to customary closing conditions and had not closed as of the filing date.